Case Report | Open Access
Mohammed H. AlShati, Mohammed M. Yaktien, Kenneth C. Katchy, "Former Mucinous Bronchioloalveolar Carcinoma Revisited", Case Reports in Medicine, vol. 2013, Article ID 284323, 3 pages, 2013. https://doi.org/10.1155/2013/284323
Former Mucinous Bronchioloalveolar Carcinoma Revisited
This is a brief case report of invasive multicentric mucinous adenocarcinoma presented at a rather young age with bronchorrhea and persistent consolidation that ended up with the patient demise; nevertheless, we demonstrate relevant radiological and pathological features with emphasis on the new classification of bronchioloalveolar carcinoma, a term that should no longer be in use.
A 35-year-old man, ex-smoker, presented to hospital with progressive dyspnea and cough productive of copious amounts of clear sputum. Several months ago, he was treated with antibiotics for presumed pneumonia, yet without significant improvement. Examination revealed oxygen saturation of 90% with bilateral chest crackles. Radiological investigations showed a mixture of multilobar consolidation, peripheral ground glass opacities with septal thickening, and multiple pulmonary nodules (Figure 1).
Bronchoalveolar lavage and transbronchial biopsies suggested malignancy and surgical lung biopsy confirmed the diagnosis of invasive multifocal mucinous adenocarcinoma (Figure 2).
The patient opted for comfort care and died few months later.
2. Learning Points
(i) Invasive mucinous adenocarcinoma, formerly known as mucinous bronchioloalveolar carcinoma (BAC), is characterized by its peripheral location, mucin overproduction, lepidic growth pattern (i.e., tumor growth along intact alveolar septa), and propensity to spread via airways and lymphatics.
(ii) Bronchorrhea (sputum production of >100 mL/day) should prompt consideration of invasive mucinous adenocarcinoma in the differential diagnosis. Other causes of bronchorrhea include bronchitis, bronchiectasis, pulmonary contusion, scorpion stings, and organophosphate poisoning.
(iii) The spectrum of radiological findings is broad and includes consolidations, air bronchograms, multifocal solid or subsolid nodules or masses, cavitations, and persistent ground glass opacities. Lower lobe predominance is common .
(iv) Treatment options are similar to those for non-small-cell adenocarcinoma with poor prognosis in patients with far-advanced multicentric invasive disease.
(v) Bronchorrhea is usually difficult to treat and can cause hypoxemia secondary to mucus related ventilation/perfusion mismatch, intrapulmonary shunt, and/or diffusion limitation. Successful use of tyrosine kinase inhibitors in those with epidermal growth factor receptor (EGFR) mutation (tested negative in our case), corticosteroids, macrolides, octreotide, and inhaled indomethacin has been reported.
(vi) BAC, a term that should be avoided, has now been replaced by five histologic categories : adenocarcinoma in situ (AIS); minimally invasive adenocarcinoma (MIA); lepidic predominant adenocarcinoma, adenocarcinoma predominantly invasive with some nonmucinous lepidic component; and invasive mucinous adenocarcinoma (formerly mucinous BAC).
(vii) Mucinous adenocarcinoma frequently expresses cytokeratins (CK) 7 and 20 but not thyroid transcription factor-1 (TTF-1), napsin-A, or CDX2. The contradictory expression of CK7 and CDX2 by mucinous subtype and pulmonary metastasis of colorectal carcinoma are important discriminatory factors in their differential diagnosis. Furthermore, mucinous adenocarcinoma is associated with frequent overexpression of K-ras but usually lacks (EGFR) mutations .
Written informed consent was obtained from the patient’s next-of-kin for publication of this report and accompanying images.
Conflict of Interests
The authors declare that they have no conflict of interests.
- J. H. Austin, K. Garg, D. Aberle et al., “Radiologic implications of the 2011 classification of adenocarcinoma of the lung,” Radiology, vol. 266, no. 1, pp. 62–71, 2013.
- W. D. Travis, E. Brambilla, M. Noguchi et al., “International association for the study of lung cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma,” Journal of Thoracic Oncology, vol. 6, no. 2, pp. 244–285, 2011.
- M. Chilosi and B. Murer, “Mixed adenocarcinomas of the lung: place in new proposals in classification, mandatory for target therapy,” Archives of Pathology & Laboratory Medicine, vol. 134, no. 1, pp. 55–65, 2010.
Copyright © 2013 Mohammed H. AlShati et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.